An interventional study of Early PT and Delayed PT in Periodontitis and Inflammation, sponsored by University of Westminster. Completed at 1 site in Brazil. Open to female participants aged 18 Years to 49 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-08-03.
Sponsored by University of Westminster · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 48 studies in Periodontitis with a site in Brazil — 7 open to participants now, 12 under way, 1 of them phase 3. Periodontitis · Brazil.
Among the 48 studies in Periodontitis with a site in Brazil, this one is the 17th largest by enrollment of the 45 interventional ones that give a count, is one of 3 that started in 2017, is one of 27 with no phase, and was the 17th registered.
1,242 studies on the registry are indexed under Periodontitis; 304 are open to participants now.
Browse Periodontitis studies →7 of the 48 studies in Periodontitis with a site in Brazil are open now. Recruiting first, the newest first:
University of Sao Paulo · Sites in Brazil
Ages 18–70
University of Sao Paulo · Sites in Brazil
Ages 18+
University of Sao Paulo · Sites in Brazil
Ages 18–70
Universidade Federal Fluminense · Sites in Brazil
Ages 18–70 · Healthy volunteers
University of Campinas, Brazil · Sites in Brazil
Ages 18+
A study can be open while its sites in Brazil have not opened yet or have stopped. Only those recruiting at a site in Brazil →
Of the 163 Periodontitis studies recruiting now, 80 (49%) set no upper age limit and 62 (38%) stop at 75 or younger; 12 take children under 18; 80 take healthy volunteers.
This study: 18 Years to 49 Years · female · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
48 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 2 · Phase 3 5 · Phase 4 9
First in 2002; this study’s year is marked. 3 started in 2017.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 70 is above the median of 44 across 850 interventional studies indexed under Periodontitis.
Median enrollment 56 across the 45 interventional studies, 67 across the 2 observational. Of the 27 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 48 have an industry lead sponsor. The 10 most frequent:
University of Westminster is the lead sponsor of 9 studies on the registry; 1 is open to participants now.
University of Westminster has 1 study filed under Periodontitis — fewer than ten, so there is no comparison to draw.
1 of the studies in Periodontitis with a site in Brazil that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07463859University of Sao PauloEffects of Periodontal Treatment Associated With Antimicrobial Photodynamic Therapy on Halitosis in Patients With Diabetes Mellitus | 2027-01-31 |
Add it to your calendar (.ics) → With an account.
Among the 48 studies in Periodontitis with a site in Brazil, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The improvement of maternal and child health remains a key issue in global health. Production and improved accessibility of healthy and nutrient-rich milk-based products could potentially tackle health and nutrition inequalities in low-income countries.
This study will assess the acceptability of a multi-component intervention, including provision of calcium/vitamin-D fortified milk and periodontal therapy (PT), for improving maternal periodontal health and metabolic and inflammatory profiles. The IMPROVE trial is a feasibility randomised controlled trial (RCT) with parallel qualitative process evaluation. The target population is low-income, pregnant, Brazilian women, with periodontitis, who have not seen a dentist in the last 6 months. A series of focus group discussions and interviews with the target population will be conducted to identify key barriers and enablers to adoption and implementation of the intervention in prenatal clinics in Rio de Janeiro/Brazil. Participants will be allocated to 4 groups: 1) early PT (during pregnancy) plus fortified milk; 2) early PT plus plain milk; 3) delayed PT (after delivery) plus fortified milk; 4) delayed PT plus plain milk.
The final results will contribute to the understanding of the significance of calcium and vitamin D for short and long-term health and the occurrence of diseases, as well as to inform the current global debate on vitamin-D supplementation and fortification policy.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
HIV
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
early periodontal therapy (during pregnancy) plus fortified milk
Other: Early PT · Dietary Supplement: Fortified Milk
early periodontal therapy (during pregnancy) plus plain milk
Other: Early PT · Dietary Supplement: Plain Milk
delayed periodontal therapy (after delivery) plus fortified milk
Other: Delayed PT · Dietary Supplement: Fortified Milk
delayed periodontal therapy (after delivery) plus plain milk
Other: Delayed PT · Dietary Supplement: Plain Milk
Women will receive conventional non-surgical periodontal therapy (PT), consisting of prophylactic dental polishing to remove the sticky bacterial film that forms on the teeth over time, scaling and root planing, as necessary throughout pregnancy, up to delivery
Also known as: Early non-surgical periodontal therapy
Women will receive conventional non-surgical PT delayed until after delivery.
Also known as: Delayed non-surgical periodontal therapy
participants will be advised to take two servings of a powdered milk-based drink enriched with calcium and vitamin D daily during breakfast and afternoon snack or supper to avoid concomitant intake of the prenatal iron supplements routinely prescribed for consumption with hot main meals (e.g. lunch or dinner). Women will be advised to consume 20 g of commercially available semi-skimmed milk powder (provided by the study) and one sachet with 500 IU of vitamin D3 and 1,2 g of a calcium supplement from milk extract (300 mg of calcium) twice a day.
Women will be advised to consume 20 g of commercially available semi-skimmed milk powder (provided by the study) and one sachet with flour (placebo).
Also known as: non-fortified milk (placebo)
Feasibility (acceptability of study design, recruitment strategy, random allocation and data collection procedures)
Feasibility will be evaluated using mixed-methods to explore intervention delivery, participants' acceptability, challenges and issues faced during the study, and recommended changes to the study design. Focus groups discussions will be held prior to trial recruitment to discuss issues regarding recruitment strategy, study design and data collection. In addition, group discussions will be held throughout the study (2nd and 3rd trimester) to assess potential barriers and facilitators to the intervention and data collection. At the end of each participant's involvement in the study, the participant will be asked to complete an anonymous, acceptability questionnaire to gain insights about participant's reactions to research participation and how acceptable the participant found study requirements and assessments were.
Time frame: From baseline till 6-8 weeks' postpartum
Recruitment rate
This will be measured by the total number of participants recruited into the study. The investigators intend to recruit 120 participants. Recruitment rate will be calculated (number of participants per month)
Time frame: one year
Adherence
number of drop-outs in each study arm. Analyses of drop-out rates (%) in four study arms. Self-reported quantity of milk consumed during the study. Number of follow-up visits. Proportion of participants who provide full data at baseline, throughout pregnancy and up to 6-8 weeks postpartum.
Time frame: From baseline till 6-8 weeks' postpartum
Changes in % of sites with bleeding on probing
Certified and calibrated dentists will conduct dental examinations pre/post-intervention. Full mouth periodontal examination will be performed at six sites per tooth, using disposable periodontal probes with coloured-coded area and mirror but without X-rays. Bleeding scores will be determined as percentage of sites with bleeding relative to the total number of sites examined.
Time frame: baseline and 6-8 weeks' postpartum
Changes in maternal blood biomarkers to assess inflammation
Blood samples will be taken to assess changes in cytokines levels: CRP, IL-6 and MMP-9.
Time frame: 10 months on average
Changes in maternal serum levels of 25(OH)D
Blood samples will be taken to assess changes in 25(OH)D levels
Time frame: 10 months on average
Changes in maternal glucose levels
Fasting blood samples will be taken to assess changes in glucose levels
Time frame: 10 months on
Changes in maternal insulin levels
Fasting blood samples will be taken to assess changes in insulin levels
Time frame: 10 months on average
Changes in maternal serum levels of calcium
Fasting blood samples will be taken to assess changes in calcium levels
Time frame: 10 months on average
Changes in maternal blood lipids levels
Fasting blood samples will be taken to assess changes in total cholesterol and HDL-c
Time frame: 10 months on average
Neonatal levels of 25(OH)D
drops of neonatal capillary blood will be collected via heel prick (200 μl) for measurement of 25(OH)D concentrations at the routine neonatal check-up
Time frame: between 8 to 22 months
Neonatal levels of calcium
drops of neonatal capillary blood will be collected via heel prick (200 μl) for measurement of calcium concentrations
Time frame: between 8 to 22 months
Plan to share: Undecided — External users will be bound by a data sharing agreement (in Portuguese and English) which will be available as part of the application to share data on the University website
Ran from Apr 2017 to primary completion in May 2018, 13 months.
Of 484 non-industry interventional studies with no phase under Periodontitis, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 31. This study's 13 months is below that.
Counting every sponsor, half of 498 studies reached it within 15 months; a quarter within 8 and three quarters within 31.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jul 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Westminster